FDA 2025 pulmonology drug alerts, including drug approvals/warnings, vaccine approvals, and medical device recalls/updates.

The prescribing information for two respiratory syncytial virus (RSV) vaccines will now include a warning for the increased ...

The prescribing information for Abrysvo ® (respiratory syncytial virus [RSV] vaccine) and Arexvy ® (RSV vaccine, adjuvanted) has been updated to include a new warning regarding the risk of ...

The estimated effectiveness of the respiratory syncytial virus (RSV) among older US veterans in the 2023-2024 respiratory ...

Expectant mothers will have access to free vaccines against respiratory syncytial virus (RSV) from next month under a major ...

Pregnant women across Australia will be offered a free vaccine to protect their babies against respiratory syncytial virus ...

In 2024, companies in the broader market that paid dividends returned around 35% of their net income and 45% of their free ...

Women who are 28-36 weeks pregnant will have access to the Pfizer-made Abrysvo vaccine, which would normally come at a cost of up to $300. Women who are 28-36 weeks pregnant will have access to ...

This week we welcomed the federal government's announcement that a respiratory syncytial virus (RSV) vaccine for pregnant women would be included on ...